Omar Boraie Chair in Genomic Science, a Hope for Cancer Patients

The Omar Boraie Chair in Genomic Science was established at Rutgers Cancer Institute, New Jersey, with the aim of helping to propel innovation research in the field of precision medicine. This is according to an article published on Newswise on October 21, 2015.

The chair was regarded as the premium level of higher education. The endued chairs expressed their commitment to a university to an academic discipline of the highest level. They also assured to show their continued support and advancement to the chair.

Omar Boraie Aspiration

The chair was named after Omar Boraie, the New Brunswick developer, who according to Yahoo.com made a pledge of $1.5 million to support it. The Omar Boraie Chair in the University was established as a Chair Challenge campaign whereby an anonymous donor was to donate 1.5 million to match to each of the donation made by the 18 chairs resulting into $3million endowment each.

By application of genomic science and precision medicine, medical professionals have changed their approach to cancer diagnoses and treatment. Rutgers Cancer Institute was the first facility in the country and the only one in the state to use genomic sequencing and precision medicine method to patient care. Today, several cancer institutes are using this approach to tumors.

Genomic sequencing has been regarded useful in helping find novel therapies for people with rare cancers, with poor prognoses and those whose treatment options have either been ineffective or limited. Similarly, advance in the use of precision medicine enhances the ability to classify cancers into sub-populations of same characteristics but different genetics. This helps predict better patient outcome and determine their specific cancer therapies.

Views of the Members Regarding the Chair

Commenting about the establishment of Rutgers Cancer Institute, Boraie said that the institution was making significant progress in the use of precision medicine for patients whose cancer is no longer responsive. He also said he was hopeful that the pledge they made would act as leverage to support those in need so that the chair would realize its goal. He expressed his hope that his family’s commitment would inspire others to do the same. Boraie has a background in chemistry and has a long-standing interest in cancer.

Other chairs named in the Omar Boraie Chair in Gnomic Science include Rutgers Cancer Institute director for transitional science and principal investigator of precision medicine, Shridar Ganesan, MD, Ph.D. Dr. Ganesan is a medical oncologist who is internationally regarded as a top academic researcher and leader.

Ganesan said on the Wall Street Journal that it was an honor to be endowed as a chair for Omar Boraie Gnomic Science. He added that through the years studying cancer, they had realized that it wasn’t a single disease but rather a collection of diseases each having unique features. He said that the pledge hay made would assist the clinical research in getting more understanding of the cancer biology which in turn would help patients suffering even from the most challenging diseases and renew their hope and that of their families.

Read More: http://www.nytimes.com/2005/03/06/realestate/at-two-extremes-of-a-housing-market.html